Eric J Hall1, Andrew H Smith2, Frank A Fish2, David P Bichell3, Bret A Mettler3, Kimberly Crum2, Prince J Kannankeril2, Andrew E Radbill4. 1. Vanderbilt University School of Medicine, Nashville, Tennessee. 2. Department of Pediatrics, Division of Cardiology, Monroe Carell Jr. Children's Hospital, Vanderbilt University Medical Center, Nashville, Tennessee. 3. Department of Cardiac Surgery, Division of Pediatric Cardiac Surgery, Monroe Carell Jr. Children's Hospital, Vanderbilt University Medical Center, Nashville, Tennessee. 4. Department of Pediatrics, Division of Cardiology, Monroe Carell Jr. Children's Hospital, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: andrew.radbill@vanderbilt.edu.
Abstract
BACKGROUND: Transplant-free survival for single right ventricle (RV) lesions remains less than 70% at 3 years. Arrhythmia burden, influence of shunt type at Norwood procedure (RV-to-pulmonary artery shunt [RVPAS] versus Blalock-Taussig shunt [BTS]), and implications for mortality risk are not well defined. METHODS: The authors performed a single-center retrospective analysis of patients with single RV lesions enrolled in a prospective study of arrhythmias after congenital heart surgery. RESULTS: Fifty-eight patients received a RVPAS and 62 received a BTS, with a median follow-up of 773 days. Overall arrhythmia incidence was 78%, two-thirds of which prompted intervention. Among all types of arrhythmias, only ventricular arrhythmias (VAs) differed by shunt type, which were more common in patients receiving an RVPAS (29% RVPAS versus 14% BTS; p = 0.049). The majority of VAs were transient (69% less than 1 minute), and typically occurred early post-Norwood procedure (median 12 days). No additional variables were associated with development of VAs. Shunt type did not influence transplant-free survival. Within the entire cohort, there was a trend toward increased mortality with prior history of VA (odds ratio, 2.90; 95% confidence interval, 0.99 to 8.90; p = 0.052). For interstage survivors to Glenn palliation, any VA associated with a 14-fold increased risk of death or transplant (hazard ratio, 14.00; 95% confidence interval, 3.66 to 53.40; p < .001). No other tachyarrhythmia or bradyarrhythmia was associated with mortality. CONCLUSIONS: In this cohort with single RV lesions and prospective rhythm surveillance, patients receiving an RVPAS at Norwood surgery had an increased incidence of VAs compared with patients with a BTS. VAs correlated with late mortality in patients who survived the interstage period.
BACKGROUND: Transplant-free survival for single right ventricle (RV) lesions remains less than 70% at 3 years. Arrhythmia burden, influence of shunt type at Norwood procedure (RV-to-pulmonary artery shunt [RVPAS] versus Blalock-Taussig shunt [BTS]), and implications for mortality risk are not well defined. METHODS: The authors performed a single-center retrospective analysis of patients with single RV lesions enrolled in a prospective study of arrhythmias after congenital heart surgery. RESULTS: Fifty-eight patients received a RVPAS and 62 received a BTS, with a median follow-up of 773 days. Overall arrhythmia incidence was 78%, two-thirds of which prompted intervention. Among all types of arrhythmias, only ventricular arrhythmias (VAs) differed by shunt type, which were more common in patients receiving an RVPAS (29% RVPAS versus 14% BTS; p = 0.049). The majority of VAs were transient (69% less than 1 minute), and typically occurred early post-Norwood procedure (median 12 days). No additional variables were associated with development of VAs. Shunt type did not influence transplant-free survival. Within the entire cohort, there was a trend toward increased mortality with prior history of VA (odds ratio, 2.90; 95% confidence interval, 0.99 to 8.90; p = 0.052). For interstage survivors to Glenn palliation, any VA associated with a 14-fold increased risk of death or transplant (hazard ratio, 14.00; 95% confidence interval, 3.66 to 53.40; p < .001). No other tachyarrhythmia or bradyarrhythmia was associated with mortality. CONCLUSIONS: In this cohort with single RV lesions and prospective rhythm surveillance, patients receiving an RVPAS at Norwood surgery had an increased incidence of VAs compared with patients with a BTS. VAs correlated with late mortality in patients who survived the interstage period.
Authors: Seshadri Balaji; Ankana Daga; David J Bradley; Susan P Etheridge; Ian H Law; Anjan S Batra; Shubayan Sanatani; Anoop K Singh; Kelly K Gajewski; Sabrina Tsao; Harinder R Singh; Svjetlana Tisma-Dupanovic; Shigeru Tateno; Motoki Takamuro; Hiromichi Nakajima; Jolien W Roos-Hesselink; Maully Shah Journal: J Thorac Cardiovasc Surg Date: 2013-10-27 Impact factor: 5.209
Authors: Bhavya Trivedi; P Brian Smith; Piers C A Barker; James Jaggers; Andrew J Lodge; Ronald J Kanter Journal: Am Heart J Date: 2011-01 Impact factor: 4.749
Authors: Richard G Ohye; Julie V Schonbeck; Pirooz Eghtesady; Peter C Laussen; Christian Pizarro; Peter Shrader; Deborah U Frank; Eric M Graham; Kevin D Hill; Jeffrey P Jacobs; Kirk R Kanter; Joel A Kirsh; Linda M Lambert; Alan B Lewis; Chitra Ravishankar; James S Tweddell; Ismee A Williams; Gail D Pearson Journal: J Thorac Cardiovasc Surg Date: 2012-08-15 Impact factor: 5.209
Authors: Douglas Y Mah; Henry Cheng; Mark E Alexander; Lynn Sleeper; Jane W Newburger; Pedro J Del Nido; Ravi R Thiagarajan; Satish K Rajagopal Journal: J Thorac Cardiovasc Surg Date: 2016-04-11 Impact factor: 5.209
Authors: Katja Zeppenfeld; Martin J Schalij; Margot M Bartelings; Usha B Tedrow; Bruce A Koplan; Kyoko Soejima; William G Stevenson Journal: Circulation Date: 2007-10-29 Impact factor: 29.690
Authors: Nancy S Ghanayem; Kerstin R Allen; Sarah Tabbutt; Andrew M Atz; Martha L Clabby; David S Cooper; Pirooz Eghtesady; Peter C Frommelt; Peter J Gruber; Kevin D Hill; Jonathan R Kaltman; Peter C Laussen; Alan B Lewis; Karen J Lurito; L LuAnn Minich; Richard G Ohye; Julie V Schonbeck; Steven M Schwartz; Rakesh K Singh; Caren S Goldberg Journal: J Thorac Cardiovasc Surg Date: 2012-07-11 Impact factor: 5.209
Authors: Megan C McFerson; Anthony C McCanta; Zhaoxing Pan; Kathryn K Collins; James Jaggers; Eduardo M da Cruz; Jon Kaufman Journal: Pediatr Cardiol Date: 2013-11-17 Impact factor: 1.655
Authors: David W Brown; Colleen Mangeot; Jeffrey B Anderson; Laura E Peterson; Eileen C King; Stacey L Lihn; Steven R Neish; Craig Fleishman; Christina Phelps; Samuel Hanke; Robert H Beekman; Carole M Lannon Journal: J Am Heart Assoc Date: 2016-01-11 Impact factor: 5.501
Authors: Matthew E Oster; Michael Kelleman; Courtney McCracken; Richard G Ohye; William T Mahle Journal: J Am Heart Assoc Date: 2016-01-13 Impact factor: 5.501
Authors: Andrew E Radbill; Andrew H Smith; Sara L Van Driest; Frank A Fish; David P Bichell; Bret A Mettler; Karla G Christian; Todd L Edwards; Prince J Kannankeril Journal: Cardiol Young Date: 2022-01-06 Impact factor: 1.023
Authors: Sarah R Fuchs; Andrew H Smith; Sara L Van Driest; Kim F Crum; Todd L Edwards; Prince J Kannankeril Journal: Heart Rhythm Date: 2018-12-05 Impact factor: 6.343